Medicenna Therapeutics Corp.
Pharmaceutical company · Toronto, Ontario, Canada · OTC: MDNAF
Medicenna Therapeutics Corp. is a pharmaceutical company headquartered in Toronto, Ontario, Canada. Its earliest recorded incorporation is in 2015. Its shares trade on OTC under the ticker MDNAF. It has reported private securities offerings to the US SEC, most recently $15 million sold in a notice filed in 2024.
Medicenna Therapeutics at a glance
What does Medicenna Therapeutics do?
Private fundraising reported to the SEC
3 Form D notices; the most recent reported $14.6 million sold (2024).
Frequently asked questions about Medicenna Therapeutics
Where is Medicenna Therapeutics headquartered?
Medicenna Therapeutics Corp. is headquartered in Toronto, Ontario, Canada.
What does Medicenna Therapeutics do?
Medicenna Therapeutics Corp. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Medicenna Therapeutics a public company?
Yes. Medicenna Therapeutics Corp. trades on OTC under the ticker MDNAF.
When was Medicenna Therapeutics founded?
The earliest incorporation on record for Medicenna Therapeutics Corp. is in 2015, according to public company registers.
Similar companies
- ProMIS Neurosciences Inc.Toronto, Ontario, Canada
- Quantum Biopharma Ltd.Toronto, Ontario, Canada
- Psyence Biomedical Ltd.Toronto, Ontario, Canada
- Intellipharmaceutics International Inc.Toronto, Ontario, Canada
- Avicanna Inc.Toronto, Ontario, Canada
- Bradmer Pharmaceuticals IncToronto, Ontario, Canada
- Organigram Global Inc.Toronto, Ontario, Canada
- Sunovion CNS Development Canada UlcToronto, Ontario, Canada
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-24. Data licences